10-propargyl-10-deazaaminopterin has been researched along with Lymphoma, T Cell, Peripheral in 28 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (10.71) | 29.6817 |
| 2010's | 21 (75.00) | 24.3611 |
| 2020's | 4 (14.29) | 2.80 |
| Authors | Studies |
|---|---|
| Altınay, S; Kural, A; Özmen, A; Tural, D; Tutar, Y | 1 |
| Kaur, H; Lee, YS; Ong, SY; Phipps, C; Tan, L | 1 |
| Francine, F; Jennifer C, Z; Salma, A; Sara Mohamed, J | 1 |
| Maeda, Y; Tobinai, K; Yeoh, EM; Zhu, J | 1 |
| Baik, D; Cho, H; Cho, S; Kang, HY; Kim, AY; Lee, H; Park, S | 1 |
| Marchi, E; O'Connor, OA; Raufi, AG | 1 |
| Amengual, J; Colbourn, D; Deng, C; O'Connor, OA; Sawas, A | 1 |
| Vose, JM | 1 |
| Gisselbrecht, C; Sibon, D | 1 |
| Ito, Y; Makita, S; Tobinai, K | 1 |
| Foss, FM; Girardi, M; Li, A; Parker, TL | 1 |
| Bhagat, G; Ma, H; O'Connor, OA | 1 |
| Altuntaş, F; Çakar, MK; Dal, MS; Doğan, M; İskender, D; Merdin, A; Ulu, BU | 1 |
| Geskin, LJ; Koch, E; Story, SK | 1 |
| Bari, A; Dondi, A; Ferri, P; Pozzi, S; Sacchi, S | 1 |
| Gooptu, M; Pro, B; Rhoades, R | 1 |
| Advani, RH; Ansell, SM; Beaven, AW; Carson, KR; Evens, AM; Foss, F; Horwitz, S; Lechowicz, MJ; Loberiza, F; Pinter-Brown, LC; Pro, B; Savage, KJ; Shustov, AR; Smith, SM; Vose, JM | 1 |
| Ahn, JS; Cho, MS; Jung, SH; Jung, SY; Kim, HJ; Kim, YK; Lee, JJ; Lee, SS; Yang, DH | 1 |
| Chihara, D; Davis, RE; Fanale, MA; Fayad, LE; Fowler, NH; Hagemeister, FB; Hosing, C; Lee, HJ; Medeiros, LJ; Miranda, RN; Nastoupil, LJ; Neelapu, SS; Nieto, YL; Noorani, M; Oki, Y; Rodriguez, MA; Romaguera, JE; Samaniego, F; Turturro, F; Wang, M; Westin, JR | 1 |
| O'Leary, HM; Savage, KJ | 1 |
| Link, BK; Rosenstein, LJ | 1 |
| Thompson, CA | 1 |
| O'Connor, OA | 1 |
| Bartlett, N; Boyd, A; Coiffier, B; Crump, M; Furman, R; Gisselbrecht, C; Goy, A; Haioun, C; Horwitz, S; Hsi, E; Jacobsen, E; Lechowicz, MJ; O'Connor, OA; Pinter-Brown, L; Popplewell, L; Pro, B; Savage, KJ; Shustov, AR; Zain, JM; Zinzani, PL | 1 |
| Foss, F | 1 |
| Elefante, A; Hui, J; Przespo, E | 1 |
13 review(s) available for 10-propargyl-10-deazaaminopterin and Lymphoma, T Cell, Peripheral
| Article | Year |
|---|---|
Pralatrexate for Peripheral T-Cell Lymphoma (PTCL): Chance Only Supports The Prepared Mind.
Topics: COVID-19; Folic Acid Antagonists; Humans; Lymphoma, T-Cell, Cutaneous; Lymphoma, T-Cell, Peripheral; Meta-Analysis as Topic; Methotrexate; Neoplasm Recurrence, Local; SARS-CoV-2; Skin Neoplasms; Systematic Reviews as Topic; United States | 2023 |
Pralatrexate injection for the treatment of patients with relapsed or refractory peripheral T-cell lymphoma.
Topics: Aminopterin; Humans; Lymphoma, T-Cell, Peripheral | 2020 |
Novel Agents in the Treatment of Relapsed or Refractory Peripheral T-Cell Lymphoma.
Topics: Aminopterin; Antineoplastic Combined Chemotherapy Protocols; Brentuximab Vedotin; Clinical Trials as Topic; Depsipeptides; Disease-Free Survival; Hydroxamic Acids; Immunoconjugates; Lymphoma, T-Cell, Peripheral; Sulfonamides; Survival Rate | 2017 |
Pralatrexate: a comprehensive update on pharmacology, clinical activity and strategies to optimize use.
Topics: Aminopterin; Clinical Trials as Topic; Drug Resistance, Neoplasm; Drug Therapy; Folic Acid Antagonists; Humans; Lymphoma, T-Cell, Peripheral; Neoplasm Recurrence, Local; Treatment Outcome | 2017 |
New perspectives in the therapeutic approach of peripheral T-cell lymphoma.
Topics: Aminopterin; Antineoplastic Combined Chemotherapy Protocols; Brentuximab Vedotin; Clinical Trials, Phase II as Topic; Depsipeptides; Humans; Hydroxamic Acids; Immunoconjugates; Lymphoma, T-Cell, Peripheral; Randomized Controlled Trials as Topic; Sulfonamides | 2018 |
Development of new agents for peripheral T-cell lymphoma.
Topics: Aminopterin; Aminopyridines; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Benzamides; Brentuximab Vedotin; China; Depsipeptides; Drug Approval; Histone Deacetylase Inhibitors; Humans; Hydroxamic Acids; Immunoconjugates; Lymphoma, T-Cell, Peripheral; Neoplasm Recurrence, Local; Sulfonamides | 2019 |
A peripheral T-cell lymphoma (PTCL) arising as a post-transplant lymphoproliferative disorder: efficacy of pralatrexate in primary refractory disease and review of the literature.
Topics: Adult; Aminopterin; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Cardiomyopathies; Deoxycytidine; Drug Resistance, Neoplasm; Female; Folic Acid Antagonists; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Heart Failure; Heart Transplantation; Humans; Lymphoma, T-Cell, Peripheral; Organoplatinum Compounds; Peripartum Period; Positron Emission Tomography Computed Tomography; Postoperative Complications; Treatment Outcome | 2019 |
The potential of pralatrexate as a treatment of peripheral T-cell lymphoma.
Topics: Aminopterin; Animals; Antineoplastic Agents; Clinical Trials as Topic; Folic Acid Antagonists; Humans; Lymphoma, T-Cell, Peripheral; Treatment Outcome | 2014 |
Current management of peripheral T-cell lymphomas.
Topics: Aminopterin; Antineoplastic Agents; Brentuximab Vedotin; Diphtheria Toxin; Histone Deacetylase Inhibitors; Humans; Immunoconjugates; Interleukin-2; Lymphoma, T-Cell, Peripheral; Molecular Targeted Therapy; Protein Kinase Inhibitors; Recombinant Fusion Proteins; Stem Cell Transplantation | 2015 |
Novel therapies in peripheral T-cell lymphomas.
Topics: Alemtuzumab; Aminopterin; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antibodies, Neoplasm; Antineoplastic Combined Chemotherapy Protocols; Clinical Trials as Topic; Deoxycytidine; Diphtheria Toxin; Enzyme Inhibitors; Gemcitabine; Humans; Immunotherapy; Interleukin-2; Lymphoma, T-Cell, Peripheral; Medical Oncology; Prognosis; Recombinant Fusion Proteins; Treatment Outcome | 2008 |
Optimizing chemotherapeutic strategies for peripheral T-cell lymphomas.
Topics: Aminopterin; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Clinical Trials as Topic; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Drug Delivery Systems; Humans; Lymphoma, T-Cell, Peripheral; Prednisone; Vincristine | 2008 |
Novel agents in development for peripheral T-cell lymphoma.
Topics: Aminopterin; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Boronic Acids; Bortezomib; Clinical Trials as Topic; Depsipeptides; Drug Design; Drugs, Investigational; Histone Deacetylase Inhibitors; Humans; Immunologic Factors; Lenalidomide; Lymphoma, T-Cell, Peripheral; Purine Nucleosides; Pyrazines; Pyrimidinones; Salvage Therapy; Thalidomide | 2010 |
Pralatrexate: a novel synthetic antifolate for relapsed or refractory peripheral T-cell lymphoma and other potential uses.
Topics: Aminopterin; Animals; Clinical Trials as Topic; Folic Acid Antagonists; Humans; Lymphoma, T-Cell, Peripheral; Neoplasm Recurrence, Local | 2012 |
3 trial(s) available for 10-propargyl-10-deazaaminopterin and Lymphoma, T Cell, Peripheral
| Article | Year |
|---|---|
A phase II study of cyclophosphamide, etoposide, vincristine and prednisone (CEOP) alternating with pralatrexate (P) as front line therapy for patients with peripheral T-cell lymphoma (PTCL): preliminary results from the T-Cell Consortium trial.
Topics: Aminopterin; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Etoposide; Female; Humans; Lymphoma, T-Cell, Peripheral; Male; Middle Aged; Prednisone; Vincristine | 2014 |
A phase II study of cyclophosphamide, etoposide, vincristine and prednisone (CEOP) Alternating with Pralatrexate (P) as front line therapy for patients with peripheral T-cell lymphoma (PTCL): final results from the T- cell consortium trial.
Topics: Adult; Aged; Aged, 80 and over; Aminopterin; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Disease Progression; Disease-Free Survival; Epirubicin; Female; Humans; Kaplan-Meier Estimate; Lymphoma, T-Cell, Peripheral; Male; Middle Aged; Prednisone; Treatment Outcome; Vincristine | 2016 |
Pralatrexate in patients with relapsed or refractory peripheral T-cell lymphoma: results from the pivotal PROPEL study.
Topics: Adult; Aged; Aged, 80 and over; Aminopterin; Drug Resistance, Neoplasm; Female; Folic Acid Antagonists; Humans; International Agencies; Lymphoma, T-Cell, Peripheral; Male; Middle Aged; Neoplasm Recurrence, Local; Prospective Studies; Remission Induction; Salvage Therapy; Standard of Care; Survival Rate; Treatment Outcome; Young Adult | 2011 |
12 other study(ies) available for 10-propargyl-10-deazaaminopterin and Lymphoma, T Cell, Peripheral
| Article | Year |
|---|---|
Pralatrexate Induces Long-Term Remission in Relapsed Subcutaneous Panniculitis-Like T-Cell Lymphoma.
Topics: Adult; Aminopterin; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Cisplatin; Cyclophosphamide; Deoxycytidine; Dexamethasone; Doxorubicin; Folic Acid Antagonists; Gemcitabine; Humans; Lymphohistiocytosis, Hemophagocytic; Lymphoma, T-Cell, Peripheral; Male; Neoplasm Recurrence, Local; Panniculitis; Prednisone; Remission Induction; Subcutaneous Fat, Abdominal; Vincristine | 2019 |
Efficacy and safety of single-agent pralatrexate for treatment of angioimmunoblastic T-cell lymphoma after failure of first line therapy: a pooled analysis.
Topics: Aminopterin; China; Humans; Japan; Lymphoma, T-Cell, Peripheral; Neoplasm Recurrence, Local; Prospective Studies; Retrospective Studies | 2020 |
Cost-utility analysis of pralatrexate for relapsed or refractory peripheral T-cell lymphoma based on a case-matched historical control study along with single arm clinical trial.
Topics: Aminopterin; Case-Control Studies; Cost-Benefit Analysis; Female; Humans; Lymphoma, T-Cell, Peripheral; Male; Neoplasm Recurrence, Local | 2020 |
Peripheral T-cell lymphoma: novel backbone.
Topics: Aminopterin; Depsipeptides; Humans; Lymphoma, T-Cell; Lymphoma, T-Cell, Peripheral | 2018 |
Effect of leucovorin administration on mucositis and skin reactions in patients with peripheral T-cell lymphoma or cutaneous T-cell lymphoma treated with pralatrexate.
Topics: Adult; Aged; Aged, 80 and over; Aminopterin; Female; Humans; Leucovorin; Lymphoma, T-Cell, Cutaneous; Lymphoma, T-Cell, Peripheral; Male; Middle Aged; Mucositis; Neoplasm Staging; Premedication; Retrospective Studies; Skin Diseases; Treatment Outcome | 2019 |
Pralatrexate induced durable response in a relapsed/refractory peripheral T-cell lymphoma patient with a history of autologous stem cell transplantation: Case report of a patient followed-up over 3 years under pralatrexate treatment.
Topics: Aged; Aminopterin; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Hematopoietic Stem Cell Transplantation; Humans; Lymphoma, T-Cell, Peripheral; Male; Recurrence | 2019 |
Preemptive leucovorin administration minimizes pralatrexate toxicity without sacrificing efficacy.
Topics: Adult; Aged; Aged, 80 and over; Aminopterin; Female; Folic Acid Antagonists; Humans; Leucovorin; Lymph Nodes; Lymphoma, T-Cell, Peripheral; Male; Mycosis Fungoides; Premedication; Skin; Tomography, X-Ray Computed | 2013 |
Pralatrexate in Combination with Bortezomib for Relapsed or Refractory Peripheral T Cell Lymphoma in 5 Elderly Patients.
Topics: Aged; Aminopterin; Antineoplastic Agents; Bortezomib; Drug Administration Schedule; Drug Therapy, Combination; Humans; Lymphoma, T-Cell, Peripheral; Male; Neoplasm Recurrence, Local; Neutropenia; Positron Emission Tomography Computed Tomography | 2016 |
The survival outcome of patients with relapsed/refractory peripheral T-cell lymphoma-not otherwise specified and angioimmunoblastic T-cell lymphoma.
Topics: Adult; Aged; Aminopterin; Antineoplastic Combined Chemotherapy Protocols; Depsipeptides; Disease-Free Survival; Female; Humans; Immunoblastic Lymphadenopathy; Lymphoma, T-Cell; Lymphoma, T-Cell, Peripheral; Male; Middle Aged; Salvage Therapy; Stem Cell Transplantation; Survival Rate; Young Adult | 2017 |
FDA approves pralatrexate for treatment of rare lymphoma.
Topics: Aminopterin; Antineoplastic Agents; Drug Approval; Folic Acid Antagonists; Humans; Lymphoma, T-Cell, Peripheral; United States; United States Food and Drug Administration | 2009 |
Pralatrexate (Folotyn) for peripheral T-cell lymphoma.
Topics: Aminopterin; Antimetabolites, Antineoplastic; Humans; Lymphoma, T-Cell, Peripheral | 2010 |
Hematology: relapsed and refractory PTCL--into the therapeutic abyss.
Topics: Aminopterin; Antineoplastic Agents; Drug Resistance, Neoplasm; Folic Acid Antagonists; Hematology; Humans; Lymphoma, T-Cell, Peripheral; Neoplasm Recurrence, Local; Salvage Therapy | 2011 |